Singular Genomics Systems Inc

Singular Genomics Systems Inc

OMIC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$50.77M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Singular Genomics Systems IncSingular Genomics Systems Inc-0.5--70%200.4
$-0.90

Current Fair Value

104.5% downside

Overvalued by 104.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$50.77 Million
Enterprise Value$48.64 Million
Earnings per Share$-39.08
Beta1.84
Outstanding Shares2,501,093

Return

Return on Equity-70.04%ROE
Return on Assets-46.27%
Return on Invested Capital-54.73%

Valuation & Multiples

P/E Ratio-0.51P/E Ratio
PEG2.06PEG
Price to Sales20.01Price to Sales
Price to Book Ratio0.41Price to Book Ratio
Enterprise Value to Revenue18.24
Enterprise Value to EBIT-0.53
Enterprise Value to Net Income-1
Total Debt to Enterprise1.04
Debt to Equity0.41Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 10, 2025
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Singular Genomics Systems Inc

138 employees

Singular Genomics Systems Insider Information FAQ

In the latest 13F quarter on Stockcircle, 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.